Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study
Yun Yong Seo (Seo YY), Yong Kyun Cho (Cho YK), Ji-Cheol Bae (Bae JC), Mi Hae Seo (Seo MH), Se Eun Park (Park SE), Eun-Jung Rhee (Rhee EJ), Cheol-Young Park (Park CY), Ki-Won Oh (Oh KW), Sung-Woo Park (Park SW), Won-Young Lee (Lee WY)
Endocrinol Metab. 2013;28(1):41-45.   Published online 2013 Mar 25     DOI: https://doi.org/10.3803/EnM.2013.28.1.41
Citations to this article as recorded by Crossref logo
Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials
Sahar Rafiee, Hamed Mohammadi, Abed Ghavami, Erfan Sadeghi, Zahra Safari, Gholamreza Askari
Complementary Therapies in Clinical Practice.2021; 42: 101281.     CrossRef
Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease
Narges Damavandi, Sirous Zeinali
Molecular Biology Reports.2021; 48(2): 1225.     CrossRef
Potential protective effect of curcumin in high-fat diet-induced nonalcoholic fatty liver disease in rats
AhmedM M. Mahmouda, NohaA.-R A. El-Hagag, HusseinI El-Bitar, Abdel-HalimM Afifi
Journal of Current Medical Research and Practice.2021; 6(1): 92.     CrossRef
Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
Mengyao Zhao, Shumin Chen, Xiaoguo Ji, Xin Shen, Jiangshan You, Xinyi Liang, Hao Yin, Liming Zhao
Pharmacological Research.2021; 166: 105517.     CrossRef
Inflammation in Metabolic Diseases and Insulin Resistance
Won-Young Lee
Cardiovascular Prevention and Pharmacotherapy.2021; 3(2): 31.     CrossRef

Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)

Kyung Soo Hong, Min Cheol Kim, June Hong Ahn
International Journal of Chronic Obstructive Pulmonary Disease.2020; Volume 15: 1005.     CrossRef
A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts
Yen-Chun Koh, Yen-Cheng Lin, Pei-Sheng Lee, Ting-Jang Lu, Kai-Yi Lin, Min-Hsiung Pan
Food & Function.2020; 11(9): 7545.     CrossRef
The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson
Biomedicine & Pharmacotherapy.2020; 131: 110785.     CrossRef
Redox Regulation by Protein S-Glutathionylation: From Molecular Mechanisms to Implications in Health and Disease
Aysenur Musaogullari, Yuh-Cherng Chai
International Journal of Molecular Sciences.2020; 21(21): 8113.     CrossRef
Long-Term Soy Protein Isolate Consumption Reduces Liver Steatosis Through Changes in Global Transcriptomics in Obese Zucker Rats
Melisa Kozaczek, Walter Bottje, Byungwhi Kong, Sami Dridi, Diyana Albataineh, Kentu Lassiter, Reza Hakkak
Frontiers in Nutrition.2020;[Epub]     CrossRef
Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto
Antioxidants.2019; 8(8): 276.     CrossRef
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri
BMC Gastroenterology.2019;[Epub]     CrossRef
Zeaxanthin Dipalmitate in the Treatment of Liver Disease
Nisma Lena Bahaji Azami, Mingyu Sun
Evidence-Based Complementary and Alternative Medicine.2019; 2019: 1.     CrossRef
A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease
Abbas Ali Sangouni, Saeid Ghavamzadeh, Atena Jamalzehi
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 2260.     CrossRef
ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population
Guo-Chao Zhong, Shan Liu, Yi-Lin Wu, Mei Xia, Jin-Xian Zhu, Fa-Bao Hao, Lun Wan, Pavel Strnad
PLOS ONE.2019; 14(12): e0225792.     CrossRef
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
Eun-Jung Rhee
Endocrinology and Metabolism.2019; 34(3): 226.     CrossRef
Telmisartan improves the metabolic, hematological and inflammasome indices in non-alcoholic fatty liver infiltration: A pilot open-label placebo-controlled study
Marwan S.M. Al-Nimer, Vian A.W. Esmail, O. Mohammad
Electronic Journal of General Medicine.2019; 16(3): em142.     CrossRef
TRUSS Exacerbates NAFLD Development by Promoting I κ B α Degradation in Mice
Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang
Hepatology.2018; 68(5): 1769.     CrossRef
Association Between Tumor Necrosis Factor-α and the Risk of Hepatic Events: A Median 3 Years Follow-Up Study
Zhi Zhu, Shuofeng Li
Hepatitis Monthly.2018;[Epub]     CrossRef
Clinical Characteristics of Non-Alcoholic Fatty Liver Disease Based on Analyses from the Kangbuk Samsung Health Study
Eun-Jung Rhee
The Journal of Korean Diabetes.2017; 18(2): 81.     CrossRef
Ezetimibe alleviates non-alcoholic fatty liver disease through the miR-16 inhibiting mTOR/p70S6K1 pathway
Xiang Wang, Yunbing Meng, Junrong Zhang
RSC Advances.2017; 7(60): 37967.     CrossRef
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
Flavia A Cimini, Ilaria Barchetta, Simone Carotti, Laura Bertoccini, Marco G Baroni, Umberto Vespasiani-Gentilucci, Maria-Gisella Cavallo, Sergio Morini
World Journal of Gastroenterology.2017; 23(19): 3407.     CrossRef
Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy
Michael Linecker, Perparim Limani, Patryk Kambakamba, Philipp Kron, Christoph Tschuor, Nicolas Calo, Michelangelo Foti, Jean-François Dufour, Rolf Graf, Bostjan Humar, Pierre-Alain Clavien
Annals of Surgery.2017; 266(2): 324.     CrossRef
Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK
Y-h Lee, M R Yun, H M Kim, B H Jeon, B-C Park, B-W Lee, E S Kang, H C Lee, Y W Park, B-S Cha
International Journal of Obesity.2016; 40(2): 356.     CrossRef
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
Feliciano Chanana Paquissi
Frontiers in Immunology.2016;[Epub]     CrossRef
Comparison of Serum Adipocytokine Levels according to Metabolic Health and Obesity Status
Tae Hoon Lee, Won Seon Jeon, Ki Joong Han, Shin Yeoung Lee, Nam Hee Kim, Hyun Beom Chae, Choel Min Jang, Kyung Mo Yoo, Hae Jung Park, Min Kyung Lee, Se Eun Park, Hyung Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinology and Metabolism.2015; 30(2): 185.     CrossRef
Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study
Min-Kyung Lee, Eun-Jung Rhee, Min Chul Kim, Byung Sub Moon, Jeong In Lee, Young Seok Song, Eun Na Han, Hyo Sun Lee, Yoonjeong Son, Se Eun Park, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
Endocrinology and Metabolism.2015; 30(4): 522.     CrossRef
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
Sanja Stojsavljević
World Journal of Gastroenterology.2014; 20(48): 18070.     CrossRef
Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
Won-Young Lee
Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef